CNQ · LYNX.CN
Lynx Resources Corp.
CA$0.14CA$0.00 (0.0%)
Lynx Resources Corp.’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
Loading market information…
TSXV · SQD.V · CAD
Stock price
Quote as of Jun 14, 2023, 02:23 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
SQI Diagnostics Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
SQI Diagnostics Inc., a company dedicated to precision medicine, specializes in the research, development, and global commercialization of expedited diagnostic testing solutions. These offerings cater to medical professionals, patients, and individual consumers alike. Among its diverse portfolio, the company offers TOR-dx, a specialized lung assessment tool that aids surgeons in evaluating the viability of donor lungs. Additionally, SQI Diagnostics provides an at-home antibody test kit for COVID-19, alongside two distinct tests for gauging COVID-19 severity: the RALI-Dx, a laboratory-based triage solution, and the RALI-fast, designed for point-of-care assessment. The company also manufactures microarray instruments, integral to various antibody testing workflows. Established in 1999, SQI Diagnostics Inc. maintains its corporate headquarters in Toronto, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:21 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
CA$0.14CA$0.00 (0.0%)
Lynx Resources Corp.’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
CA$0.51-CA$0.01 (-1.92%)
Sweet Earth Holdings Corporation’s quoted price sits in the upper half of its reported 52-week range, 31.08% below the high.
CA$0.06CA$0.00 (0.0%)
Tryp Therapeutics Inc.: Healthcare · Biotechnology.
CA$0.04+CA$0.01 (+16.67%)
Willow Biosciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.17% below the high.
CA$0.01CA$0.00 (0.0%)
Heritage Cannabis Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
CA$0.04CA$0.00 (0.0%)
Empower Clinics Inc.’s quoted price sits in the lower half of its reported 52-week range, 11.11% below the high.
CA$0.10CA$0.00 (0.0%)
Asep Medical Holdings Inc’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.00$0.00 (0.0%)
StageZero Life Sciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 91.45% below the high.
